Jeong YH - Search Results

1

A meta-analysis of randomized controlled trials appraising the efficacy and safety of cilostazol after coronary artery stent implantation.

Jang JS, Jin HY, Seo JS, Yang TH, Kim DK, Kim DS, Kim DK, Seol SH, Kim DI, Cho KI, Kim BH, Park YH, Je HG, Jeong YH, Kim WJ, Lee JY, Lee SW. Jang JS, et al. Among authors: jeong yh. Cardiology. 2012;122(3):133-43. doi: 10.1159/000339238. Epub 2012 Jul 24. Cardiology. 2012. PMID: 22832424 Review.

2

Results and predictors of angiographic restenosis and long-term adverse cardiac events after drug-eluting stent implantation for aorto-ostial coronary artery disease.

Park DW, Hong MK, Suh IW, Hwang ES, Lee SW, Jeong YH, Kim YH, Lee CW, Kim JJ, Park SW, Park SJ. Park DW, et al. Among authors: jeong yh. Am J Cardiol. 2007 Mar 15;99(6):760-5. doi: 10.1016/j.amjcard.2006.10.028. Epub 2007 Jan 22. Am J Cardiol. 2007. PMID: 17350360

3

Impact of significant chronic kidney disease on long-term clinical outcomes after drug-eluting stent versus bare metal stent implantation.

Jeong YH, Hong MK, Lee CW, Park DW, Kim YH, Kim JJ, Park SW, Park SJ. Jeong YH, et al. Int J Cardiol. 2008 Mar 28;125(1):36-40. doi: 10.1016/j.ijcard.2007.02.026. Epub 2007 May 22. Int J Cardiol. 2008. PMID: 17521753

4

Long-term outcome of simultaneous kissing stenting technique with sirolimus-eluting stent for large bifurcation coronary lesions.

Kim YH, Park DW, Suh IW, Jang JS, Hwang ES, Jeong YH, Lee SW, Lee SW, Lee CW, Hong MK, Kim JJ, Park SW, Park SJ. Kim YH, et al. Among authors: jeong yh. Catheter Cardiovasc Interv. 2007 Nov 15;70(6):840-6. doi: 10.1002/ccd.21254. Catheter Cardiovasc Interv. 2007. PMID: 17621657

5

Biomarkers on admission for the prediction of cardiovascular events after primary stenting in patients with ST-elevation myocardial infarction.

Jeong YH, Lee SW, Lee CW, Hong MK, Kim JJ, Park SW, Park SJ, Park DW, Kim YH. Jeong YH, et al. Clin Cardiol. 2008 Dec;31(12):572-9. doi: 10.1002/clc.20403. Clin Cardiol. 2008. PMID: 19072878 Free PMC article.

6

Serum B-type natriuretic peptide on admission can predict the 'no-reflow' phenomenon after primary drug-eluting stent implantation for ST-segment elevation myocardial infarction.

Jeong YH, Kim WJ, Park DW, Choi BR, Lee SW, Kim YH, Lee CW, Hong MK, Kim JJ, Park SW, Park SJ. Jeong YH, et al. Int J Cardiol. 2010 May 28;141(2):175-81. doi: 10.1016/j.ijcard.2008.11.189. Epub 2009 Jan 13. Int J Cardiol. 2010. PMID: 19144424

7

Randomized comparison of adjunctive cilostazol versus high maintenance dose clopidogrel in patients with high post-treatment platelet reactivity: results of the ACCEL-RESISTANCE (Adjunctive Cilostazol Versus High Maintenance Dose Clopidogrel in Patients With Clopidogrel Resistance) randomized study.

Jeong YH, Lee SW, Choi BR, Kim IS, Seo MK, Kwak CH, Hwang JY, Park SW. Jeong YH, et al. J Am Coll Cardiol. 2009 Mar 31;53(13):1101-9. doi: 10.1016/j.jacc.2008.12.025. J Am Coll Cardiol. 2009. PMID: 19324253 Free article. Clinical Trial.

8

Adding cilostazol to dual antiplatelet therapy achieves greater platelet inhibition than high maintenance dose clopidogrel in patients with acute myocardial infarction: Results of the adjunctive cilostazol versus high maintenance dose clopidogrel in patients with AMI (ACCEL-AMI) study.

Jeong YH, Hwang JY, Kim IS, Park Y, Hwang SJ, Lee SW, Kwak CH, Park SW. Jeong YH, et al. Circ Cardiovasc Interv. 2010 Feb 1;3(1):17-26. doi: 10.1161/CIRCINTERVENTIONS.109.880179. Epub 2010 Jan 26. Circ Cardiovasc Interv. 2010. PMID: 20118150 Clinical Trial.

9

Interaction analysis between genetic polymorphisms and pharmacodynamic effect in patients treated with adjunctive cilostazol to dual antiplatelet therapy: results of the ACCEL-TRIPLE (Accelerated Platelet Inhibition by Triple Antiplatelet Therapy According to Gene Polymorphism) study.

Kim IS, Jeong YH, Park Y, Yoon SE, Kwon TJ, Park JR, Hwang SJ, Koh EH, Kwak CH, Hwang JY, Kim S. Kim IS, et al. Among authors: jeong yh. Br J Clin Pharmacol. 2012 Apr;73(4):629-40. doi: 10.1111/j.1365-2125.2011.04131.x. Br J Clin Pharmacol. 2012. PMID: 22007612 Free PMC article.

10

Meta-analysis of cytochrome P450 2C19 polymorphism and risk of adverse clinical outcomes among coronary artery disease patients of different ethnic groups treated with clopidogrel.

Jang JS, Cho KI, Jin HY, Seo JS, Yang TH, Kim DK, Kim DS, Seol SH, Kim DI, Kim BH, Park YH, Je HG, Jeong YH, Lee SW. Jang JS, et al. Among authors: jeong yh. Am J Cardiol. 2012 Aug 15;110(4):502-8. doi: 10.1016/j.amjcard.2012.04.020. Epub 2012 May 15. Am J Cardiol. 2012. PMID: 22591668

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

547 results

Search Page